Skip to Main Content Skip to Main Content

HSC Medicine, Dentistry and Healthcare Sciences Current Awareness Bulletins: Rheumatology

Rheumatology current awareness bulletin

Frequency: Bi-monthly

Links to articles in the current and previous 2 issues of this bulletin are displayed below.

To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk

April 2025

2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer

Axial spondyloarthritis (JAMA review)

Cure as a treatment target in rheumatoid arthritis and systemic sclerosis—achievable aim or mission impossible? FOREUM stimulates new industry-academia collaboration

Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study

EULAR recommendations for the treatment of systemic sclerosis: 2023 update

See also: Results from the international collaborative systematic literature review informing the 2023 EULAR recommendations for the treatment of systemic sclerosis

Evidence that autoantibody production may be driven by acute Epstein-Barr virus infection in Sjögren's disease

Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults

Exploring the role of neutrophil extracellular traps in systemic lupus erythematosus

IĸBζ as a central modulator of inflammatory arthritis pathogenesis

Long COVID for the rheumatologist: current understanding and approach to management

Lupus and inflammatory bowel disease share a common set of microbiome features distinct from other autoimmune disorders

Microbiome research in autoimmune and immune-mediated inflammatory diseases: lessons, advances and unmet needs

Multimorbidity patterns and rheumatoid arthritis disease outcomes: findings from a multicenter, prospective cohort

Patterns of imaging requests by general practitioners for people with musculoskeletal complaints

Rheum for improvement? Delayed diagnosis of juvenile idiopathic arthritis: a narrative review

Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologics

Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease

Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis (new Cochrane intervention review)

Tumor necrosis factor (TNF) inhibitors for psoriatic arthritis (new Cochrane intervention review)

Uncovering specific genetic-respiratory disease endotypes for rheumatoid arthritis risk

Sources

Annals of the Rheumatic Diseases (Jan-Mar); Arthritis & Rheumatology (Feb-Mar); Arthritis Care & Research (Feb-Mar); Cochrane Library (Jan-Feb); JAMA (Feb); Rheumatic Disease Clinics of North America (Feb)

February 2025

Barriers to, facilitators of, and interventions to support treat-to-target implementation in rheumatoid arthritis: a systematic review

Clinical information on imaging referrals for suspected or known axial spondyloarthritis: recommendations from the Assessment of Spondyloarthritis International Society (ASAS)

Early identification of rheumatoid arthritis: does it induce treatment-related cost savings?

EULAR/PReS recommendations for the diagnosis and management of Still’s disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still’s disease

See also: Efficacy and safety of therapies for Still’s disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still’s disease; and Systemic juvenile idiopathic arthritis and adult-onset Still’s disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still’s disease

Evaluation of hematological markers as prognostic tools in rheumatoid arthritis

Fine particulate matter components and risk of rheumatoid arthritis: a large general Canadian open cohort study

Functional patient-reported outcome measures after hip or knee arthroplasty

Gut microbiome and osteoarthritis: insights from the naturally occurring canine model of osteoarthritis

Journey through discovery of 75 years glucocorticoids: evolution of our knowledge of glucocorticoid receptor mechanisms in rheumatic diseases

Lifestyle discussions facilitate self-management in RA: a qualitative study of patients’ perceptions

Long-term mortality following SARS-CoV-2 infection in rural versus urban dwellers with autoimmune or inflammatory rheumatic disease: a retrospective cohort analysis from the National COVID Cohort Collaborative

Neighborhood characteristics and walking behavior among adults with arthritis: a national health interview survey study

Neighborhood disadvantage and knee osteoarthritis pain: do sleep and catastrophizing play a role?

Rheumatoid arthritis and COVID-19 outcomes: a systematic review and meta-analysis

The risk of lung cancer in rheumatoid arthritis and rheumatoid arthritis–associated interstitial lung disease

Total hip replacement or resistance training for severe hip osteoarthritis

Understanding the role of type I interferons in cutaneous lupus and dermatomyositis: toward better therapeutics

Sources

Annals of the Rheumatic Diseases (Dec); Arthritis & Rheumatology (Dec-Jan); Arthritis Care & Research (Dec-Jan); BMC Rheumatology (Nov-Dec); NEJM (Oct)

December 2024

2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases

American College of Rheumatology white paper: the effects of climate change on rheumatic conditions—an evolving landscape and a path forward

Another notch in the belt of rheumatoid arthritis

B-cell depletion in autoimmune diseases

Curating genetic associations with rheumatologic autoimmune diseases to improve patient outcomes

Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease

EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update

The explication of race in rheumatology disparities

From fibrositis to fibromyalgia to nociplastic pain: how rheumatology helped get us here and where do we go from here?

How does osteoarthritis education influence knowledge, beliefs, and behavior in people with knee and hip osteoarthritis? A systematic review

Impact of climate change on rheumatic diseases: a scoping review

Inflammatory tissue priming: novel insights and therapeutic opportunities for inflammatory rheumatic diseases

Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations

Misdiagnosis, missed diagnosis, and delayed diagnosis of lupus: a qualitative study of rheumatologists

Old before their time? The impact of osteoarthritis on younger adults

Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment

Pathological autoantibody internalisation in myositis

Patient research partner involvement in rheumatology research: a systematic literature review informing the 2023 updated EULAR recommendations for the involvement of patient research partners

Recommendations for early referral of individuals with suspected polymyalgia rheumatica

Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study

Sources

Annals of the Rheumatic Diseases (Oct-Nov); Arthritis and Rheumatology (Oct-Nov); Arthritis Care and Research (Oct-Nov); Journal of Climate Change and Health, The (Sep-Oct)

Disclaimer

The Healthcare Library cannot guarantee the correctness or completeness of the information in these bulletins. The information is subject to change and we cannot guarantee it will remain up-to-date. It is your responsibility to check the accuracy and validity of the information. These bulletins are the property of the Healthcare Library; please credit us if re-using or distributing content from them.